Results 41 to 50 of about 6,810 (223)

Interleukin-27-polarized HIV-resistant M2 macrophages are a novel subtype of macrophages that express distinct antiviral gene profiles in individual cells: implication for the antiviral effect via different mechanisms in the individual cell-dependent manner

open access: yesFrontiers in Immunology
IntroductionInterleukin (IL)-27 is an anti-viral cytokine. IL-27-treated monocyte-derived macrophages (27-Mac) suppressed HIV replication. Macrophages are generally divided into two subtypes, M1 and M2 macrophages.
Tomozumi Imamichi   +13 more
doaj   +1 more source

Computational Optimisation of EtAMA1 Reveals Its Potential as a Vaccine Candidate Against Eimeria tenella

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Eimeria tenella is one of the main causes of coccidiosis in poultry, with increasing drug resistance highlighting the need for alternate control strategies. This study identified Eimeria tenella AMA1 (EtAMA1) as a promising vaccine candidate through structural analysis, epitope prediction, immune simulation, and molecular docking, which demonstrated ...
Nooran Mahomed Rafeer   +2 more
wiley   +1 more source

Designing a multi-epitope subunit vaccine against chikungunya virus using immunoinformatics and molecular simulation approaches

open access: yesScientific Reports
Chikungunya is a mosquito-borne viral illness that is responsible for increased rates of infection and major public health consequences, but no approved vaccine is available yet.
Sk.Faisal Ahmed   +8 more
doaj   +1 more source

Immunoinformatics‐Based Design of a Multi‐Epitope Vaccine Targeting a Conserved Copper–Associated Protein in Neisseria gonorrhoeae

open access: yesBiotechnology and Applied Biochemistry, Volume 73, Issue 5, Page 2373-2387, October 2026.
ABSTRACT Neisseria gonorrhoeae poses an urgent public health challenge due to rapidly increasing antimicrobial resistance and the absence of an effective vaccine. Targeting conserved bacterial pathways involved in essential physiological processes may provide new opportunities for vaccine antigen discovery.
Sinethemba H. Yakobi   +1 more
wiley   +1 more source

Targeting Amastigote and Trypomastigote Phases: Multi‐Epitope Vaccine Strategy Against Trypanosoma cruzi

open access: yesBiotechnology and Applied Biochemistry, Volume 73, Issue 5, Page 2457-2481, October 2026.
ABSTRACT Effective vaccines against Trypanosoma cruzi, the causative agent of Chagas disease, are urgently needed. Here, we report the design and in silico validation of a novel multiepitope vaccine construct targeting the key surface proteins ASP‐2 and gp82. Using a comprehensive immunoinformatics pipeline, we identified and selected 38 potent T‐cell (
Maria Karolaynne da Silva   +8 more
wiley   +1 more source

Integrated Functional and scRNA-Seq Analyses Reveal Convergence of M-CSF– and GM-CSF–Derived Macrophages Following IL-27 Polarization

open access: yesCells
Macrophages differentiated with macrophage colony-stimulating factor (M-CSF) (M-Mac) are widely used as an experimental model. Interleukin 27 (IL-27)-polarized M-Mac (27M-Mac) suppresses HIV replication; however, the effects of IL-27 polarization on ...
Tomozumi Imamichi   +9 more
doaj   +1 more source

CelltrackR: An R package for fast and flexible analysis of immune cell migration data

open access: yesImmunoInformatics, 2021
Visualization of cell migration via time-lapse microscopy has greatly advanced our understanding of the immune system. However, subtle differences in migration dynamics are easily obscured by biases and imaging artifacts.
Inge M.N. Wortel   +5 more
doaj   +1 more source

Human Cytomegalovirus Genetic Diversity, Clinical Relevance, and Emerging Insights

open access: yesReviews in Medical Virology, Volume 36, Issue 5, September 2026.
ABSTRACT Human cytomegalovirus (HCMV) is a globally prevalent virus that poses a significant public health concern, especially for newborns and immunocompromised patients, causing a wide range of infections. Clinical outcomes associated with HCMV infection include congenital disease, graft rejection in transplant recipients, and life‐threatening ...
Hajar Y. AlQahtani   +2 more
wiley   +1 more source

Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive Immunoinformatics methods

open access: yes, 2021
Visceral leishmaniasis (VL) is a severe disease with particular endemicity in over 80 countries worldwide. There is no approved human vaccine against VL in the market.
Majidiani, H.   +13 more
core   +2 more sources

Systematic review of reverse vaccinology and immunoinformatics data for non-viral sexually transmitted infections [PDF]

open access: yes, 2023
Sexually Transmitted Infections (STIs) are a public health burden rising in developed and developing nations. The World Health Organization estimates nearly 374 million new cases of curable STIs yearly.
ARISTÓTELES GOÉS NETO   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy